T-group (topology)

233.1.1 MHC antigen-recognition domain

Ligands and drugs

4,020
Member domains
1,716
with ligand contacts (≤ 4 Å)
42.7% of members
1,490
with DrugDomain annotations
37.1% of members
1,202
with a DrugBank compound
29.9% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 233.1.1 belongs to X-group 233 MHC antigen-recognition domain, which binds 8.1 ligand superclasses per 20 proteins, broader than 60% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine478
DB03796PLMPalmitic Acid31
DB12232AGHAlpha-galactosylceramide17
DB04661CIScis-tetracosenoyl sulfatide9
DB00145GLYGlycine8
DB010481KXAbacavir7
DB02676B3P2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol7
DB00151CYSCysteine6
DB04473FUCalpha-L-fucose6
DB00125ARGArginine5
DB00149LEULeucine5
DB02175MLAMalonic acid5
DB03309NHEN-cyclohexyltaurine5
DB03345BMEMercaptoethanol5
DB00134METMethionine3
DB08231MYRMyristic acid3
DB08357P4GDiethylene glycol diethyl ether3
DB00586DIFDiclofenac2
DB00847DHLCysteamine2
DB02144PIE1,2-diacyl-sn-glycero-3-phosphoinositol2

Most frequently bound compounds

PDB ligandNameDomains in contact
NAG2-acetamido-2-deoxy-beta-D-glucopyranose513
CLCHLORIDE ION101
NAmetalSODIUM ION91
ZNmetalZINC ION37
PLMPALMITIC ACID31
2LJ1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol30
IODIODIDE ION30
MGmetalMAGNESIUM ION27
30WN-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide21
PTYPHOSPHATIDYLETHANOLAMINE20
CAmetalCALCIUM ION18
AGHN-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE17
CDmetalCADMIUM ION17
Q871-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol12
D12DODECANE11
CUYtetracosyl octadecanoate10
CIS(15Z)-N-((1S,2R,3E)-2-HYDROXY-1-{[(3-O-SULFO-BETA-D-GALACTOPYRANOSYL)OXY]METHYL}HEPTADEC-3-ENYL)TETRACOS-15-ENAMIDE9
EKG(2R)-2,3-dihydroxypropyl hexadecanoate9
GLYGLYCINE8
MYRMYRISTIC ACID8